NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
-2.33%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.75B
AUM Growth
+$2.75B
Cap. Flow
+$170M
Cap. Flow %
6.17%
Top 10 Hldgs %
80.34%
Holding
44
New
6
Increased
1
Reduced
2
Closed

Sector Composition

1 Healthcare 83.27%
2 Technology 3.99%
3 Communication Services 1.93%
4 Consumer Discretionary 1.79%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RIGL icon
26
Rigel Pharmaceuticals
RIGL
$701M
$8.85M 0.32%
3,243,150
TRVN
27
DELISTED
Trevena, Inc.
TRVN
$8.77M 0.32%
3,811,691
AFMD
28
DELISTED
Affimed
AFMD
$7.97M 0.29%
3,888,888
VRNA
29
Verona Pharma
VRNA
$9.18B
$7.77M 0.28%
+666,666
New +$7.77M
TCON
30
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$6.62M 0.24%
2,759,217
DZSI
31
DELISTED
DZS Inc. Common Stock
DZSI
$5.74M 0.21%
956,255
HIVE
32
DELISTED
AEROHIVE NETWORKS, INC.
HIVE
$5.61M 0.2%
1,121,080
-3,188,611
-74% -$15.9M
SYBX icon
33
Synlogic
SYBX
$17.2M
$4.97M 0.18%
2,974,811
TRIL
34
DELISTED
Trillium Therapeutics Inc.
TRIL
$4.62M 0.17%
+1,050,000
New +$4.62M
CSBR icon
35
Champions Oncology
CSBR
$98.3M
$4.02M 0.15%
1,562,500
ORKA
36
Oruka Therapeutics, Inc. Common Stock
ORKA
$586M
$3.51M 0.13%
1,460,209
VIRX
37
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.51M 0.13%
1,298,274
ARQL
38
DELISTED
Arqule Inc
ARQL
$3.13M 0.11%
2,520,316
ROKA
39
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$2.31M 0.08%
893,471
AKTX
40
Akari Therapeutics
AKTX
$20.7M
$2.08M 0.08%
452,167
PRTK
41
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.6M 0.06%
66,245
OREX
42
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.08M 0.04%
370,900
AVTX icon
43
Avalo Therapeutics
AVTX
$123M
$341K 0.01%
595,435
GYRE icon
44
Gyre Therapeutics
GYRE
$698M
$202K 0.01%
43,492